Patient info

Pantoprazole 20 mg gastro-resistant tablets – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
Prescription only (POM)
Medicine strength:
20 mg
Contains active substance:

Patient leaflet - Pantoprazole 20 mg gastro-resistant tablets

1. What Pantoprazole is and what it is used for

Pantoprazole contains the active substance pantoprazole. Pantoprazole is a selective “proton pump inhibitor”, a medicine which reduces the amount of acid produced in your stomach. It is used for treating acid-related diseases of the stomach and intestine.

Pantoprazole is used to treat adults and adolescents 12 years of age and above for

  • Symptoms (e.g. heartburn, acid regurgitation, pain on swallowing) associated to

    gastro- oesophageal reflux disease caused by reflux of acid from the stomach.

  • Long-term management of reflux oesophagitis (inflammation of the oesophagus

    accompanied by the regurgitation of stomach acid) and preventing its return. Pantoprazole is used to treat adults for

  • Preventing duodenal and stomach ulcers caused by non-steroidal anti-

    inflammatory drugs (NSAIDs, for example, ibuprofen) in patients at risk who need to take NSAIDs continuously.

2. What you need to know before you take Pantoprazole

Do not take Pantoprazole

  • If you are allergic to Pantoprazole or to any of the other ingredients of this

    medicine (listed in section 6).

  • If you are allergic to medicines containing other proton pump inhibitors.

Warnings and precautions

Talk to your doctor, pharmacist or nurse before taking Pantoprazole

  • If you have severe liver problems. Please tell your doctor if you have ever had

    problems with your liver in the past. Your doctor will check your liver enzymes more frequently, especially when you are taking Pantoprazole as a long-term treatment. In the case of a rise of liver enzymes the treatment should be stopped.

  • If you need to take medicines called NSAIDs continuously and receive

    Pantoprazole because you have an increased risk of developing stomach and intestinal complications. Any increased risk will be assessed according to your own personal risk factors such as your age (65 years old or more), a history of stomach or duodenal ulcers or of stomach or intestinal bleeding.

  • If you have reduced body stores or risk factors for reduced vitamin B12 and

    receive long-term treatment with pantoprazole. As with all acid reducing agents, Pantoprazole may lead to a reduced absorption of vitamin B12. Please contact your doctor if you notice any of the following symptoms, which could indicate low levels of Vitamin B12:

    • Extreme tiredness or lack of energy
    • Pins and needles
    • Sore or red tongue, mouth ulcers
    • Muscle weakness
    • Disturbed vision
    • Problems with memory, confusion, depression.
  • If you are taking HIV protease inhibitors such as atazanavir (for the treatment of

    HIV-infection) at the same time as Pantoprazole, ask your doctor for specific advice.

  • Taking a proton pump inhibitor like Pantoprazole, especially over a period of

    more than one year, may slightly increase your risk of fracture in the hip, wrist or spine. Tell your doctor if you have osteoporosis (reduced bone density) or if you have been told that you are at risk of getting osteoporosis (for example, if you are taking steroids).

  • If you are on Pantoprazole for more than three months it is possible that the

    levels of magnesium in your blood may fall. Low levels of magnesium can be seen as fatigue, involuntary muscle contractions, disorientation, convulsions, dizziness or increased heart rate. If you get any of these symptoms, please tell your doctor promptly. Low levels of magnesium can also lead to a reduction in potassium or calcium levels in the blood. Your doctor may decide to perform regular blood tests to monitor your levels of magnesium.

  • If you have ever had a skin reaction after treatment with a medicine similar to

    Pantoprazole that reduces stomach acid.

  • If you get a rash on your skin, especially in areas exposed to the sun tell your

    doctor as soon as you can, as you may need to stop your treatment with Pantoprazole. Remember to also mention any other ill-effects like pain in your joints.

    • Serious skin reactions including Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS) and erythema multiforme, have been reported in association with pantoprazole treatment. Stop using pantoprazole and seek medical attention immediately if you notice any of the symptoms related to these serious skin reactions described in section 4.
    • If you are due to have a specific blood test (Chromogranin A).

Tell your doctor immediately, before or after taking this medicine, if you notice any of the following symptoms, which could be a sign of another, more serious, disease:

  • An unintentional loss of weight
  • Vomiting, particularly if repeated
  • Vomiting blood; this may appear as dark coffee grounds in your vomit
  • You notice blood in your stools; which may be black or tarry in appearance
  • Difficulty in swallowing or pain when swallowing
  • You look pale and feel weak (anaemia)
  • Chest pain
  • Stomach pain
  • Severe and/or persistent diarrhoea, because this medicine has been associated with a small increase in infectious diarrhoea.

Your doctor may decide that you need some tests to rule out malignant disease because Pantoprazole also alleviates the symptoms of cancer and could cause delay in diagnosing it. If your symptoms continue in spite of your treatment, further investigations will be considered.

If you take Pantoprazole on a long-term basis (longer than 1 year) your doctor will probably keep you under regular surveillance. You should report any new and exceptional symptoms and circumstances whenever you see your doctor.

Children and adolescents

Pantoprazole is not recommended for use in children as it has not been proven to work in children below 12 years of age.

Other medicines and Pantoprazole

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.

This is because Pantoprazole may influence the effectiveness of other medicines, so tell your doctor if you are taking:

  • Medicines such as ketoconazole, itraconazole and posaconazole

    (used to treat fungal infections) or erlotinib (used for certain types of cancer) because Pantoprazole may stop these and other medicines from working properly.

  • Warfarin and phenprocoumon, which affect the thickening, or thinning of the blood. You may need further checks.
  • Medicines used to treat HIV-infection, such as atazanavir.
  • Methotrexate (used to treat rheumatoid arthritis, psoriasis, and cancer) – if you are taking methotrexate your doctor may temporarily stop your Pantoprazole treatment because Pantoprazole can increase levels of methotrexate in the blood.
  • Fluvoxamine (used to treat depression and other psychiatric diseases) – if you are taking fluvoxamine your doctor may reduce the dose.
  • Rifampicin (used to treat infections).
  • St John's wort (Hypericum perforatum) (used to treat mild depression). Talk to your doctor before taking pantoprazole if you are due to have a specific urine test (for THC; Tetrahydrocannabinol).

Pregnancy, breast-feeding and fertility

There are no adequate data from the use of Pantoprazole in pregnant women. Excretion into human milk has been reported.

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

You should use this medicine, only if your doctor considers the benefit for you greater than the potential risk for your unborn child or baby.

Driving and using machines

Pantoprazole has no or negligible influence on the ability to drive and use machines.

If you experience side effects like dizziness or disturbed vision, you should not drive or operate machines.

Pantoprazole contains Lactose

Tell your doctor if you are lactose-intolerant or intolerant to other sugars. Pantoprazole contains sodium

This medicine contains less than 1 mmol sodium (23 mg) per gastro-resistant tablet, that is so to say essentially 'sodium-free'.

Pantoprazole contains propylene glycol

This medicine contains 0.5 mg propylene glycol in each 20 mg gastro-resistant tablet. This may cause alcohol-like symptoms.

3. How to take Pantoprazole

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Method of administration

Take the tablets 1-hour before a meal without chewing or breaking them and swallow them whole with some water.

The recommended dose is:

Version : 04

Dimension: 240 x 400 mm

Colour: Colour Black

Supersede: 2075155

UK (Unit-V)

Pantoprazole 20 mg Leaflet (Variation-MHRA)

4409 4408

Adults and adolescents 12 years of age and above

To treat symptoms (e.g. heartburn, acid regurgitation, pain on swallowing) associated to gastro-oesophageal reflux disease

The usual dose is one tablet a day. This dose usually brings relief within 2 - 4 weeks

  • at most after another 4 weeks. Your doctor will tell you how long to continue taking the medicine. After this, any recurring symptoms can be controlled by taking one tablet daily, when required.

For long-term management and for preventing the return of reflux oesophagitis The usual dose is one tablet a day. If the illness returns, your doctor can double the dose, in which case you can use Pantoprazole 40 mg tablets instead, one a day. After healing, you can reduce the dose back again to one tablet 20 mg a day.

Adults

To prevent duodenal and stomach ulcers in patients who need to take NSAIDs continuously

The usual dose is one tablet a day.

Patients with liver problems

If you suffer from severe liver problems, you should not take more than one 20 mg tablet a day.

Use in children and adolescents

These tablets are not recommended for use in children below 12 years.

If you take more Pantoprazole than you should

Tell your doctor or pharmacist. There are no known symptoms of overdose.

If you forget to take Pantoprazole

Do not take a double dose to make up for a forgotten dose. Take your next normal dose at the usual time.

If you stop taking Pantoprazole

Do not stop taking these tablets without first talking to your doctor or pharmacist.

If you have any further questions about the use of this medicine, ask your doctor, pharmacist or nurse.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

If you get any of the following side effects, stop taking these tablets and tell your doctor immediately, or contact the casualty department at your nearest hospital:

  • Serious allergic reactions (frequency rare: may affect up to 1 in 1,000

    people): swelling of the tongue and/or throat, difficulty in swallowing, hives (nettle rash), difficulties in breathing, allergic facial swelling (Quincke's oedema / angioedema), severe dizziness with very fast heartbeat and heavy sweating.

  • Serious skin conditions (frequency not known: frequency cannot be estimated

    from the available data): you may notice one or more of the following - blistering of the skin and rapid deterioration of your general condition, erosion (including slight bleeding) of eyes, nose, mouth/lips or genitals, or skin sensitivity/rash, particularly in areas of skin exposed to light/the sun. You may also have joint pain or flu-like symptoms, a fever, swollen glands (e.g. in the armpit) and blood tests may show changes in certain white blood cells or liver enzymes

  • reddish non-elevated, target-like or circular patches on the trunk, often with

    central blisters, skin peeling, ulcers of mouth, throat, nose, genitals and eyes. These serious skin rashes can be preceded by fever and flu-like symptoms (Stevens Johnson syndrome, toxic epidermal necrolysis).

  • widespread rash, high body temperature and enlarged lymph nodes

    (DRESS syndrome or drug hypersensitivity syndrome).

  • Other serious conditions (frequency not known: frequency cannot be

    estimated from the available data): yellowing of the skin or whites of the eyes (severe damage to liver cells, jaundice) or fever, rash, and enlarged kidneys sometimes with painful urination and lower back pain (serious inflammation of the kidneys), possibly leading to kidney failure.

Other side effects are:

  • Common (may affect up to 1 in 10 people):

    Benign polyps in the stomach.

  • Uncommon (may affect up to 1 in 100 people):

    Headache; dizziness; diarrhoea; feeling sick, vomiting; bloating and flatulence (wind); constipation; dry mouth; abdominal pain and discomfort; skin rash, exanthema, eruption; itching; feeling weak, exhausted or generally unwell; sleep disorders; fracture in the hip, wrist or spine.

  • Rare (may affect up to 1 in 1,000 people):

    Distortion or complete lack of the sense of taste; disturbances in vision such as blurred vision; hives; pain in the joints; muscle pains; weight changes; raised body temperature; high fever; swelling of the extremities (peripheral oedema); allergic reactions; depression; breast enlargement in males.

  • Very Rare (may affect up to 1 in 10,000 people):

    Disorientation.

  • Not known (frequency cannot be estimated from the available data):

    Hallucination, confusion (especially in patients with a history of these symptoms); feeling of tingling, prickling, pins and needles, burning sensation or numbness, rash, possibly with pain in the joints, inflammation in the large bowel, that causes persistent watery diarrhoea.

Side effects identified through blood tests:

  • Uncommon (may affect up to 1 in 100 people):

    an increase in liver enzymes.

    • Rare (may affect up to 1 in 1,000 people):

      an increase in bilirubin; increased fat levels in blood; sharp drop in circulating granular white blood cells, associated with high fever.

    • Very Rare (may affect up to 1 in 10,000 people):

      a reduction in the number of blood platelets, which may cause you to bleed or bruise more than normal; a reduction in the number of white blood cells, which may lead to more frequent infections; coexisting abnormal reduction in the number of red and white blood cells, as well as platelets.

    • Not known (frequency cannot be estimated from the available data): decreased level of sodium, magnesium, calcium or potassium in blood

      (see section 2)

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme website www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Pantoprazole

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date, which is stated on the carton after 'EXP'. The expiry date refers to the last day of that month.

Storage below 30 °C.

Store in the original package.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Pantoprazole contains

  • The active substance is pantoprazole. Each tablet contains 20 mg pantoprazole

    (as sodium sesquihydrate).

  • The other ingredients are:
  • Core: lactose monohydrate, hydroxypropylcellulose, calcium stearate, sodium carbonate, sodium laurilsulfate.
  • Coating: hypromellose, ferric oxide yellow (E 172), propylene glycol, titanium dioxide (E 171), methacrylic acid-ethyl acrylate copolymer (1:1), triethyl citrate, polysorbate 80, carnauba wax.
  • Printing ink: shellac, black iron oxide (E172), propylene glycol.

What Pantoprazole looks like and contents of the pack

Yellow to pale yellow, oval, biconvex, gastro-resistant tablets imprinted "H125" on one side with black ink and plain on other side. Approximate size 8.80 mm X 4.60 mm.

Pantoprazole 20 mg are available in blister pack of 28 gastro-resistant tablets.

Marketing Authorisation Holder

Amarox Limited

Congress House, 14 Lyon Road

Harrow, Middlesex HA1 2EN

United Kingdom

Manufacturer

Pharmadox Healthcare Ltd.

KW20A Kordin Industrial Park

Paola, PLA 3000

Malta

Amarox Limited

Congress House, 14 Lyon Road

Harrow, Middlesex HA1 2EN

United Kingdom

This leaflet was last revised in 01/2026.

2106585

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 49445/0026

Last revision stated in the text: January 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Pantoprazole 20 mg gastro-resistant tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Pantoprazole
Strength 20 mg
Pharmaceutical form Gastro-resistant tablet
Yellow oval, biconvex enteric coated tablets plain on both sides
(Approximately 8.45 mm x 4.2 mm).
How is it taken Oral
Excipients Mannitol (E421), Crospovidone (Type-A), Sodium carbonate anhydrous, Calcium stearate, Hydroxy propyl methyl cellulose 5cP (E464), Povidone (K-25) (E1201), Propylene glycol (E1520), Titanium dioxide (E171), Iron oxide yellow (E172), Methacrylic acid and ethyl acrylate copolymer dispersion (1:1) [Polysorbate 80, Sodium Lauryl sulphate], Triethyl citrate (E1505)
Pack sizes 28 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 4 years
Storage Do not store above 30°C.
Drug group (ATC) Proton pump inhibitors
  1. A Alimentary tract and metabolism drugs
    1. A02 Drugs for acid related disorders
      1. A02B Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
        1. A02BC Proton pump inhibitors for peptic ulcer and GORD
          1. A02BC02 pantoprazole
Marketing authorisation PL 34771/0158 (first authorised 13 November 2013), PL 49445/0026
Marketing authorisation holder Macleods Pharma UK Limited
Codes GTIN 5060608560790, 8901463118856 · BNF 01030500

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.3.0 of 26 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.